pmc logo image
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
Jiun-Horng Chang, Dorota M Gertig, Xiaoqing Chen, Gillian S Dite, Mark A Jenkins, Roger L Milne, Melissa C Southey, Margaret RE McCredie, Graham G Giles, Georgia Chenevix-Trench, John L Hopper, Amanda B Spurdle
Breast Cancer Res. 2005; 7(4): R513–R521. Published online 2005 May 12. doi: 10.1186/bcr1040
PMCID:
PMC1175068
Abstract Full Text PDF–211K
 Is Cited by the Following 3 Articles in this Archive:
CYP17 MspA1 Polymorphism and Age at Menarche: a Meta-Analysis
Yu-Fang Pei, Lei Zhang, Hong-Wen Deng, Volodymyr Dvornyk
Dis Markers. Author manuscript; available in PMC 2009 September 22.
Published in final edited form as: Dis Markers. 2008; 25(2): 87–95.
PMCID:
PMC2748958
Abstract Full Text PDF–331K
CYP17 and breast cancer: no overall effect, but what about interactions?
Julian Little, Jacques Simard
Breast Cancer Res. 2005; 7(6): 238–242. Published online 2005 September 20. doi: 10.1186/bcr1320
PMCID:
PMC1410734
Abstract Full Text PDF–61K
CYP17 gene polymorphism in relation to breast cancer risk: a case-control study
Kristjana Einarsdóttir, Tove Rylander-Rudqvist, Keith Humphreys, Susanne Ahlberg, Gudrun Jonasdottir, Elisabete Weiderpass, Kee Seng Chia, Magnus Ingelman-Sundberg, Ingemar Persson, Jianjun Liu, Per Hall, Sara Wedrén
Breast Cancer Res. 2005; 7(6): R890–R896. Published online 2005 September 14. doi: 10.1186/bcr1319
PMCID:
PMC1410739
Abstract Full Text PDF–170K Supplementary Material
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk